mhurhangee/ep-ind-claims huggingface dataset:
A method for obtaining at least one structure of a nano-capsule including at least one nanometer-sized capsule capable of permitting the encapsulation of a compound, wherein said method includes the following steps: - at least one layer of resin is deposited on a substrate layer; - said layer of resin is structured by low-voltage electronic lithography or by optical lithography or nanoimprint lithography, so as to obtain at least one cavity in the thickness of said layer of resin, said cavity having a depth p smaller than the thickness E of said layer of resin; - an isotropic deposition of at least one layer of an encapsulating material is performed by cathode sputtering under vacuum of said material; - the cavity or cavities are sealed with a sealing material; - the layer of resin is dissolved by dipping in a suitable solvent. - at least one layer of resin is deposited on a substrate layer; - said layer of resin is structured by low-voltage electronic lithography or by optical lithography or nanoimprint lithography, so as to obtain at least one cavity in the thickness of said layer of resin, said cavity having a depth p smaller than the thickness E of said layer of resin; - an isotropic deposition of at least one layer of an encapsulating material is performed by cathode sputtering under vacuum of said material; - the cavity or cavities are sealed with a sealing material; - the layer of resin is dissolved by dipping in a suitable solvent.
Device for transferring at least one ring into a holding device, characterised in that the device comprises a spreading mechanism which comprises a slider, rods arranged movably on the slider and at least two spreading arms which are arranged movably on a crown having a longitudinal axis, and on the rods, wherein the slider and/or the crown, the longitudinal axis of which is coaxial to an axis, are arranged movably on the axis, and wherein on the spreading arms at least one ring to be transferred into the holding device is arranged in such a way that a ring arranged on the spreading arms can slide on the spreading arms.
A terminal device communicating with an Evolved Universal Terrestrial Radio Access Network, EUTRAN, the terminal device comprising a reception unit (10, 11) that is adapted to receive a PBCH, a PDCCH, and a PDSCH in a downlink in a serving cell, a PBCH, and a PDSCH in the downlink in a non-serving cell other than the serving cell, and a physical channel in a link between terminal devices in the non-serving cell; and a decoding unit (10, 13) that is adapted to decode the PDSCH in the downlink of the non-serving cell in a case that the terminal device is configured to perform transmission and reception in the link between the terminal devices in the non-serving cell, wherein the PDSCH in the downlink of the non-serving cell carries a system information block 18 indicating a pool of D2D resources reserved in the non-serving cell, and a part of the D2D resources is used for the transmission in the link in the non-serving cell.
Extracorporeal blood treatment apparatus with - a control device for controlling opening and closing of an arterial line with simultaneous closing and opening of a venous line in a single-lumen arrangement, with which untreated blood is taken through the single-lumen arrangement and the arterial line, passed through a blood treatment device and treated blood is fed back through the venous line and the single-lumen-arrangement, - an arterial line container which is arranged in the arterial line in front of the blood treatment device, - a venous line container which is arranged in the venous line following the blood treatment device, - a sensor device for detecting an amount of treated blood being above a limit value in the venous line container, - a sensor device for detecting an amount of untreated blood being below a limit value in the arterial line container, - an arterial line closure device for closing the arterial line with simultaneous opening of the venous line in response to a signal A which is transmitted by the sensor device to the arterial line closure device, - a venous line closure device for closing the venous line with simultaneous opening of the arterial line in response to a signal B which is transmitted by the sensor device to a venous line closure device, and - at least one pump for conveying a phase volume V Phase with a pumping rate Q BP, characterized in that if the actually conveyed actual value V act of the phase volume deviates from the nominal value V nom of the phase volume, the control device regulates the pumping rate Q BP of the at least one pump so that this deviation ΔV tends to be nil, wherein V nom is predetermined for the first phase at the beginning of the dialysis and corresponds for each further phase to the actually conveyed actual value V act of the phase volume of the preceding phase. - a control device for controlling opening and closing of an arterial line with simultaneous closing and opening of a venous line in a single-lumen arrangement, with which untreated blood is taken through the single-lumen arrangement and the arterial line, passed through a blood treatment device and treated blood is fed back through the venous line and the single-lumen-arrangement, - an arterial line container which is arranged in the arterial line in front of the blood treatment device, - a venous line container which is arranged in the venous line following the blood treatment device, - a sensor device for detecting an amount of treated blood being above a limit value in the venous line container, - a sensor device for detecting an amount of untreated blood being below a limit value in the arterial line container, - an arterial line closure device for closing the arterial line with simultaneous opening of the venous line in response to a signal A which is transmitted by the sensor device to the arterial line closure device, - a venous line closure device for closing the venous line with simultaneous opening of the arterial line in response to a signal B which is transmitted by the sensor device to a venous line closure device, and - at least one pump for conveying a phase volume V Phase with a pumping rate Q BP,
A device for changing a flow direction through a heat exchanger, comprising a valve housing and a rotatable valve member arranged inside the valve housing, said valve housing comprising a first end, a second end and a centre axis extending between said first and second ends (9, 8), wherein the device comprises a first port, a second port, a third port and a fourth port, said first end being provided with the first port, and said second end being provided with the third port and the fourth port, wherein the valve member is rotatable between a first position and a second position and, in the first position, defines a conduit between the first port and the third port and, in the second position, defines a conduit between the first port and the fourth port, characterised in that the valve member is rotatable around an axis of rotation offset from the centre axis, said axis of rotation extending through the centre of the first port, and the first port is angularly displaced 90° around the centre axis in relation to the third and fourth ports (31, 32).
A prepreg comprising a resin and unidirectionally aligned reinforcement fibers, the prepreg being sheet-shaped, the prepreg having slits with a depth capable of cutting off the reinforcement fibers, and the prepreg including reinforcement fibers A cut by the slits to a length of 10 to 50 mm; and reinforcement fibers B having a length equivalent to 50% or more of the sheet length of the prepreg in the alignment direction of the reinforcement fibers, wherein the surface area in a plan view of a band section containing the reinforcement fibers B is 1.4% to 35.0% relative to the total surface in a plan view of the prepreg, and at least one end of the reinforcement fibers B is positioned at an edge of the prepreg in the alignment direction of the reinforcement fibers, band sections formed from the reinforcement fibers A cut by the slits, and band sections containing the reinforcement fibers B are alternately arranged over the entire surface of the prepreg, and the width Wn of a band section containing the reinforcement fibers B is from 0.5 mm to 10.0 mm, and the distance Wp between one band section and another band section, both containing the reinforcement fibers B, is from 5 mm to 150 mm.
An anti-HIV antibody, wherein said antibody is PG9 having a heavy chain comprising the amino acid sequence of SEQ ID NO: 28, and a light chain comprising the amino acid sequence of SEQ ID NO: 30.
A controller configured to: interpret an exhaust temperature value of an aftertreatment system receiving exhaust gas produced by an internal combustion engine, an ambient temperature value, and a urea injection amount of a urea injector positioned upstream of an SCR catalyst of the aftertreatment system; determine a urea deposit amount in response to the exhaust temperature value, the ambient temperature value, and the urea injection amount; interpret a stored NH 3 amount on the SCR catalyst; determine an NH 3 release amount in response to the exhaust temperature value and the stored NH 3 amount; provide an elevated NO x output operation in response to the NH 3 release amount; and initiate a desoot regeneration event for a particulate filter of the aftertreatment system in response to the urea deposit amount by operating the internal combustion engine at a urea decomposition exhaust temperature. interpret an exhaust temperature value of an aftertreatment system receiving exhaust gas produced by an internal combustion engine, an ambient temperature value, and a urea injection amount of a urea injector positioned upstream of an SCR catalyst of the aftertreatment system; determine a urea deposit amount in response to the exhaust temperature value, the ambient temperature value, and the urea injection amount; interpret a stored NH 3 amount on the SCR catalyst; determine an NH 3 release amount in response to the exhaust temperature value and the stored NH 3 amount; provide an elevated NO x output operation in response to the NH 3 release amount; and initiate a desoot regeneration event for a particulate filter of the aftertreatment system in response to the urea deposit amount by operating the internal combustion engine at a urea decomposition exhaust temperature.
Filter cartridge, comprising a filter medium configured as an elongate bellows, the bellows being connected at the first longitudinal end thereof to a base and at the second longitudinal end thereof to a cover, and the bellows enveloping a central passage, the bellows being prism-shaped, the backs of the folds of the bellows extending parallel to the longitudinal axis of said bellows, characterized in that in corner regions of the bellows a strip or screen is attached to the bellows.
An isolated recombinant human rotavirus group C virus-like particle consisting of human rotavirus group C VP6 protein and a human rotavirus group C VP7 protein.
A likelihood generation device included in a receiving apparatus that receives a code-modulated signal including n-k information bits and k parity bits in N-dimensional arrangement, where N is a natural number greater than or equal to four, and n and k are natural numbers with k<n, the likelihood generation device comprising: a likelihood derivation unit (51a, 51b) configured to determine, by using a table that includes an L-dimensional address space and stores a likelihood in each of the L-dimensional address spaces, likelihoods of an information bit and a parity bit that are transmitted by the code-modulated signal received, where L is a natural number with L<N; wherein the likelihood generation device is characterized in that it further comprises: a likelihood correction unit configured to update, among the likelihoods determined by the likelihood derivation unit (51a, 51b), the likelihood of the information bit on a basis of a rule for generation of the parity bit.
A comb olefin block copolymer comprising a soft backbone and hard or crystalline side chains wherein the olefin block copolymer has a rheology ratio in the range of from 25.7 to 80.
Electrical supply apparatus comprising an input for connecting the electrical supply apparatus to a power supply system which provides an AC voltage as input voltage (Uin), comprising an output for connecting the electrical supply apparatus to a load, wherein the output provides a DC voltage (Uout) as output voltage, comprising a rectifier, which rectifies the input voltage (Uin) into a rectified input voltage (Upfc), comprising a PFC module, which comprises a smoothing device for smoothing the rectified input voltage (Upfc) and an active power factor correction device, wherein the power factor correction device is designed to shape, in a manner depending on a time-dependent current waveform signal, a time-dependent supply current for the smoothing device in such a way that the time-dependent input current (Ipfc) into the PFC module is matched to the current waveform signal, comprising a control module, which generates the current waveform signal for the PFC module, in particular for the power correction device, wherein the control module generates the curve shape of the current waveform signal during the operation of the electrical supply apparatus independently of the input voltage (Uin) and temporally synchronizes the current waveform signal with the input voltage (Uin) or a derivative of the input voltage, in particular the directional input voltage (Upfc), and a phase shifter device, which enables a phase shift of the current waveform signal, characterized in that the phase shift is set so as to correct or compensate for reactive currents in the electrical supply apparatus caused by reactive current generators and wherein the current waveform pattern half-cycle is set to 0 in at least one marginal region for the time duration which corresponds to the phase shift, such that in the case of a, more particularly inductive, phase shift, the current waveform pattern half-cycle is set to 0 in the marginal region, such that the input current (Ipfc) is set to zero for the time period between the zero crossing of the input voltage (Uin) and the zero crossing of the unchanged current waveform signal.
A method implemented in a user agent, UA, comprising a processor and a memory device storing instructions executable by the processor to implement the method, the method comprising: transmitting, in a media access control, MAC, control element from the UA to an access node, power headroom-related information for a number of aggregated carriers, the number of aggregated carriers comprising a plurality of aggregated carriers that is less than or equal to a total number of the aggregated carriers, the number of aggregated carriers comprising at least a first carrier and a second carrier, wherein the MAC control element includes a bitmap, the bitmap having a first bit with a first value indicating that the MAC control element includes a first power headroom value for the first carrier and a second bit with a second value indicating that the MAC control element does not include a second power headroom value for the second carrier; wherein the bitmap has a length equal to a number of reporting carriers among the number of aggregated carriers. transmitting, in a media access control, MAC, control element from the UA to an access node, power headroom-related information for a number of aggregated carriers, the number of aggregated carriers comprising a plurality of aggregated carriers that is less than or equal to a total number of the aggregated carriers, the number of aggregated carriers comprising at least a first carrier and a second carrier, wherein the MAC control element includes a bitmap, the bitmap having a first bit with a first value indicating that the MAC control element includes a first power headroom value for the first carrier and a second bit with a second value indicating that the MAC control element does not include a second power headroom value for the second carrier; wherein the bitmap has a length equal to a number of reporting carriers among the number of aggregated carriers.
A shaving razor system comprising: a. a handle having an elongated gripping portion with a proximal end portion and a distal end portion, a heat delivering element mounted to the proximal end portion of the handle, the heat delivering element comprising a skin contacting surface; b. a power source positioned within the handle, the power source is in electrical communication with the heat delivering element, the power source having a power from about 4 Watts to about 8 Watts; c. a removable shaving razor cartridge mounted to the proximal end of the handle, the removable shaving razor cartridge having a housing with a guard, a cap and at least one blade mounted to the housing between the guard and the cap, characterized in that the heat delivering element is able to increase the temperature of the skin contacting surface from an initial temperature in air of 25 °C to an elevated temperature in air of 43 °C in less than 5 seconds, the heat delivering element having a thermal mass of from about 0.08 J/°C to about 0.50 J/°C, and the heat delivering element having a mean conductivity of from about 0.10 W/cm-°C to about 0.60 W/cm-°C, and the heat delivering element having a heat conducting distance from about 0.02 cm to about 0.2 cm. a. a handle having an elongated gripping portion with a proximal end portion and a distal end portion, a heat delivering element mounted to the proximal end portion of the handle, the heat delivering element comprising a skin contacting surface; b. a power source positioned within the handle, the power source is in electrical communication with the heat delivering element, the power source having a power from about 4 Watts to about 8 Watts; c. a removable shaving razor cartridge mounted to the proximal end of the handle, the removable shaving razor cartridge having a housing with a guard, a cap and at least one blade mounted to the housing between the guard and the cap, characterized in that the heat delivering element is able to increase the temperature of the skin contacting surface from an initial temperature in air of 25 °C to an elevated temperature in air of 43 °C in less than 5 seconds, the heat delivering element having a thermal mass of from about 0.08 J/°C to about 0.50 J/°C, and the heat delivering element having a mean conductivity of from about 0.10 W/cm-°C to about 0.60 W/cm-°C, and the heat delivering element having a heat conducting distance from about 0.02 cm to about 0.2 cm.
An isolated polypeptide having glucoamylase activity, selected from the group consisting of: (a) a polypeptide comprising an amino acid sequence having at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, such as at least 95%, at least 97%, at least 98%, at least 99% or even 100% identity to amino acids 20 to 573 of SEQ ID NO: 2; (b) a polypeptide comprising an amino acid sequence having at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, such as at least 95%, at least 97%, at least 98%, at least 99% or even 100% identity to the catalytic domain shown as amino acids 21 to 472 of SEQ ID NO: 2. (a) a polypeptide comprising an amino acid sequence having at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, such as at least 95%, at least 97%, at least 98%, at least 99% or even 100% identity to amino acids 20 to 573 of SEQ ID NO: 2; (b) a polypeptide comprising an amino acid sequence having at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, such as at least 95%, at least 97%, at least 98%, at least 99% or even 100% identity to the catalytic domain shown as amino acids 21 to 472 of SEQ ID NO: 2.
An in vitro method of producing peripheral blood stem cells (mobPBSC) with improved properties of blood vessel formation, the method comprising: providing human-derived peripheral blood that has been pre-treated with granulocyte colony stimulating factor (G-CSF); separating a layer of mononuclear cells from the blood; and treating the mononuclear cells with an activated platelet supernatant. providing human-derived peripheral blood that has been pre-treated with granulocyte colony stimulating factor (G-CSF); separating a layer of mononuclear cells from the blood; and treating the mononuclear cells with an activated platelet supernatant.
An agent derived from a haematophagous arthropod that binds complement C5 for use in the treatment or prevention of myasthenia gravis, wherein the agent that binds complement C5 is: (a) a protein comprising or consisting of amino acids 19 to 168 of the amino acid sequence of SEQ ID NO: 2; (b) a protein comprising or consisting of amino acids 1 to 168 of the amino acid sequence of SEQ ID NO: 2; (c) a homologue having greater than 60% sequence identity to the protein as defined in (a) or (b); or (d) a fragment of the protein as defined in (a) or (b) or of a homologue as defined in (c), wherein said fragment retains the ability to bind complement C5. (a) a protein comprising or consisting of amino acids 19 to 168 of the amino acid sequence of SEQ ID NO: 2; (b) a protein comprising or consisting of amino acids 1 to 168 of the amino acid sequence of SEQ ID NO: 2; (c) a homologue having greater than 60% sequence identity to the protein as defined in (a) or (b); or (d) a fragment of the protein as defined in (a) or (b) or of a homologue as defined in (c), wherein said fragment retains the ability to bind complement C5.